tiprankstipranks
Lexington Biosciences (LXGTF)
:LXGTF
US Market

Lexington Biosciences (LXGTF) Financial Statements

Compare
8 Followers

Lexington Biosciences Financial Overview

Lexington Biosciences's market cap is currently $212.80K. The company's EPS TTM is $; its P/E ratio is ―; Lexington Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating IncomeC$ -157.83K---C$ -533.53K
EBITDAC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net Income----C$ -1.27M
Balance Sheet
Cash & Short-Term InvestmentsC$ 0.00C$ 0.00C$ 664.00C$ 27.64KC$ 12.82K
Total AssetsC$ 0.00C$ 0.00C$ 664.00C$ 27.64KC$ 12.82K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 843.48K
Net DebtC$ 0.00C$ 0.00C$ -664.00C$ -27.64KC$ 830.65K
Total LiabilitiesC$ 988.79KC$ 811.41KC$ 1.82MC$ 1.52MC$ 1.05M
Stockholders' EquityC$ -988.79KC$ -811.41KC$ -1.82MC$ -1.49MC$ -1.04M
Cash Flow
Free Cash FlowC$ 0.00C$ -664.00C$ -26.97KC$ -325.19KC$ -210.27K
Operating Cash FlowC$ 0.00C$ -664.00C$ -26.97KC$ -325.19KC$ -210.27K
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 340.00KC$ 115.77K
Currency in CAD

Lexington Biosciences Earnings and Revenue History

Lexington Biosciences Debt to Assets

Lexington Biosciences Cash Flow

Lexington Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis